Experts discuss why accurately recognizing CIS in patients with suspected NMIBC is essential to preventing disease progression, guiding surveillance, and expanding treatment and clinical trial opportunities.
Kenneth Beck, MD
Advertisement
Articles by Kenneth Beck, MD
Experts discuss practical strategies to improve the detection of CIS through closer urologist-pathologist collaboration, optimized biopsy techniques, and complementary diagnostic tools.
Experts discuss why CIS is frequently underrecognized, highlighting the subtle clinical and cystoscopic features of the disease and the importance of integrating multiple factors to improve detection.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
2
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
3
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
4
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
5